Ideagen PLC Director Dealing and Total Voting Rights (5185M)
September 17 2019 - 1:00AM
UK Regulatory
TIDMIDEA
RNS Number : 5185M
Ideagen PLC
17 September 2019
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Director Dealing and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
Ben Dorks, Chief Executive Officer of the Company, has exercised
1,000,000 share options with an exercise price of 22.38 pence each
over the ordinary shares of 1 pence each in the capital of the
Company ("Ordinary Shares" and the "Exercise") and subsequently
sold 650,000 Ordinary Shares at a price of 147.50 pence per
Ordinary Share (the "Sale").
Following the Exercise and Sale, Mr. Dorks' beneficial interest
in Ordinary Shares of the Company has increased by 350,000 to
2,350,533 Ordinary Shares representing 1.06% of the total voting
rights of the Company.
Application has been made to the London Stock Exchange for the
1,000,000 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 23 September
2019.
After Admission, the total number of Ordinary Shares in issue
will be 220,818,344 and the total number of voting rights will
therefore be 220,818,344. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
The information communicated in this announcement includes
inside information for the purposes of Article 7 of Regulation
596/2014
Enquiries:
Ideagen plc 01629 699100
David Hornsby, Executive Chairman
Ben Dorks, Chief Executive
Graeme Spenceley, Finance Director
finnCap Limited 020 7220 0500
Henrik Persson/James Thompson
(Nomad)
Alice Lane (ECM)
Canaccord Genuity 020 7523 8000
Simon Bridges
Richard Andrews
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted
on the London Stock Exchange AIM market (Ticker: IDEA.L).
The Group provides IRM software and services to organisations
operating within highly regulated industries such as aviation,
banking and finance and life science, with its main operational
premises spread throughout the UK, EU, US, Middle East and SE
Asia.
With an excellent portfolio of software products including
Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its
clients reduce costs, improve operational efficiency, strengthen
compliance and oversight and anticipate and manage every detail of
risk.
Currently, more than 4,700 organisations use Ideagen's products
including seven of the top 10 UK accounting firms, all of the top
aerospace and defence companies and 75% of the world's leading
pharmaceutical firms.
Ideagen's diverse and varied customer base includes many
well-known, global brands such as British Airways, Aggreko, BAE,
Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank,
Meggitt, Heineken, Johnson Matthey, Haeco Group and European
Central Bank. As well as this, Ideagen counts 180 hospitals across
the UK and US amongst its client base.
For further information please visit www.ideagen.com
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Ben Dorks
2. Reason for the Notification
a) Position/status Chief Executive
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Exercise of Options over Ordinary Shares
c) Price(s) and volume(s) -
d) Aggregated information:
-- Aggregated volume 1,000,000 options over ordinary shares of 1p each
-- Price exercised
e) Date of the transaction 16 September 2019
f) Place of the transaction London Stock Exchange AIM market (XLON)
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Ben Dorks
2. Reason for the Notification
a) Position/status Chief Executive
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a) Name Ideagen plc
b) LEI 213800KS1MLITOVNYC85
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Financial instrument, type of Ordinary Shares of 1p each
instrument
Identification code GB00B0CM0C50
b) Nature of the transaction Sale of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
147.5p 650,000
d) Aggregated information:
-- Aggregated volume 650,000 ordinary shares of 1p each sold at 147.5p per
-- Price ordinary share
e) Date of the transaction 16 September 2019
f) Place of the transaction London Stock Exchange AIM market (XLON)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCUNVNRKWAKAAR
(END) Dow Jones Newswires
September 17, 2019 02:00 ET (06:00 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2024 to May 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From May 2023 to May 2024
